Scandion Oncology announces that its Chairman of the Board has bought 6000 shares in Scandion "one big-pharma expressed interest buying the WHOLE company, can get price we simply cannot say no to" Enormt signal

Scandion Oncology bildades 2017 genom en avknoppning av vissa tillgångar från Spotlight Stock Market till Nasdaq First North Growth Market.

Nasdaq First North GM Sweden (SE) Price. Pre-money valuation. Time. Files. IPO. 5.85 SEK. 43.7M SEK. Scandion Oncology A/S stock price. Today's STU:8VY chart, history & news.

Scandion oncology share price

April 12, 2021. Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that, since December 2020 when its shareholdings in Scandion Oncology fell below 5%, Saniona has sold its remaining shares of Scandion Oncology A/S (Nasdaq First North Growth Market: SCOL) on the open market. As a result of these transactions, … Scandion Oncology A/S ("Scandion Oncology" or "the Company") today announces that the Chairman, Vice Chairman and Chief Medical Officer of the Company have bought shares in Scandion Oncology. The shares have been acquired in the daily trading on Spotlight Stock Market. Scandion Oncology A/S (“Scandion Oncology”) announces that its Chairman of the Board, Dr. Peter Høngaard Andersen, has bought additional 6000 shares in Scandion Oncology resulting in a total holding on 37.839 shares in the Company.

The trading in Scandion Oncology’s subscription option, SCOL TO 1, will take place from August 8, 2019. One (1) subscription options, SCOL TO 1, entitles the owner to subscribe for one (1) new share to a price of SEK 5.20. Please see the company’s webpage for the full terms of the subscription option. Information

Nyheder & Pressemeddelelse. Analyser.

Find the latest Scandion Oncology A/S (SCOL.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Klicka här för att följa aktiekursen i realtid Scandion Oncology A/S SCOL - Scandion Oncology A/S Share Price. SEK17.05 -0.5 -2.6% Last Trade - 05/03/21. Sector Healthcare RiskRating. Speculative. Size 0.48 (2.4974%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.

Klicka här för att följa aktiekursen i realtid 0.48 (2.4974%) 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.
Who is raffi musiker

Strong assets with patent rights: Long patent protection (until 2036 and 2037) for our two major assets in development.

6,761.47. With that in mind, shares in Scandion Oncology A/s have been in an uptrend in recent months, and the question now for investors is whether that price strength will continue.
Starta företag på åland

SE0009921075, 4040. Kambi Group Plc, KAMBI, SEK, MT0000780107, 4050 Scandion Oncology, SCOL, SEK, DK0061031895, 2010. Scout Gaming Group

19.74. Trading abbreviation SCOL. ISIN-/Trading code DK0061031895. Number of shares 32.135.544 Votes each 1 Köp aktier i Scandion Oncology - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. SCOL:FN Stockholm Stock Quote - Scandion Oncology A/S - Bloomberg Markets. DJIA.

2021-04-01

Latest stock price today and the US's most active stock market forums. 3.

See insights on Scandion Oncology including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Scandion Oncology A/S is a biotechnology company with the mission to address one of the most important challenges in modern oncology - the effective treatment of cancer which has developed resistance towards existing cancer medicine. Its first-in-class lead compound, SCO-101, is an add-on to chemoth Scandion Oncology was listed on Spotlight Stock Market November 8th 2018.They develop drugs that target anti-cancer drug resistance to improve patient outcome 2 dagar sedan · Since Saniona began selling its shares of Scandion Oncology in 2020, the total sales have generated gross proceeds of approximately USD 14.6 million (SEK 126 million), the majority of which was Scandion Oncology, ordinary share. DK0061031895, 8VY, SCOL · Today · 1 M · 3 M · 6 M · 1 Y · 3 Y. Scandion Oncology A/S is a biotechnology company with the mission to address one of the most SHARE.